Abstract
The potential of flavonoids to act as anti-tumor agents has been recognized but not fully understood because flavonoids are acting at several stages in cancer progression with distinct structure-function relationships. A whole family of structurally different flavonoids is herein described by reviewing some critical aspects of their pro-oxidant behavior in vitro/vivo and in cell systems by which they may work as antioxidants. Different classes of flavonoids (chalcones, flavones, isoflavones, flavanols, flavanones and anthocyanins) are synthetically mimicked using natural product structure-antioxidant activity relationships that are relevant for their enhanced function against cancer as well as severe inflammation conditions under which an increased oxidative stress is often implicated. In the context of the common mechanisms of flavonoid action, clinical data on benefits of flavonoids in fighting against cancer are discussed. A structural basis needed to improve antioxidant activity of these agents is elaborated in more detail.
Keywords: Action, Anthocyanin, Anti-cancer agent, Antioxidant, Anti-tumor activity, Cell line, Chalcone, Clinical data, Cytotoxic activity, Flavone, Flavonoid, Flavanol, Flavanone, Flavopiridol, Function, Isoflavone, Mechanism, Quercetin, SAR, Structure
Anti-Cancer Agents in Medicinal Chemistry
Title:Experimental and Theoretical Advances in Functional Understanding of Flavonoids as Anti-Tumor Agents
Volume: 13 Issue: 2
Author(s): Bandarugattu V. Babu, Naveen K. Konduru, Waro Nakanishi, Satoko Hayashi, Naseem Ahmed and Petar M. Mitrasinovic
Affiliation:
Keywords: Action, Anthocyanin, Anti-cancer agent, Antioxidant, Anti-tumor activity, Cell line, Chalcone, Clinical data, Cytotoxic activity, Flavone, Flavonoid, Flavanol, Flavanone, Flavopiridol, Function, Isoflavone, Mechanism, Quercetin, SAR, Structure
Abstract: The potential of flavonoids to act as anti-tumor agents has been recognized but not fully understood because flavonoids are acting at several stages in cancer progression with distinct structure-function relationships. A whole family of structurally different flavonoids is herein described by reviewing some critical aspects of their pro-oxidant behavior in vitro/vivo and in cell systems by which they may work as antioxidants. Different classes of flavonoids (chalcones, flavones, isoflavones, flavanols, flavanones and anthocyanins) are synthetically mimicked using natural product structure-antioxidant activity relationships that are relevant for their enhanced function against cancer as well as severe inflammation conditions under which an increased oxidative stress is often implicated. In the context of the common mechanisms of flavonoid action, clinical data on benefits of flavonoids in fighting against cancer are discussed. A structural basis needed to improve antioxidant activity of these agents is elaborated in more detail.
Export Options
About this article
Cite this article as:
V. Babu Bandarugattu, K. Konduru Naveen, Nakanishi Waro, Hayashi Satoko, Ahmed Naseem and M. Mitrasinovic Petar, Experimental and Theoretical Advances in Functional Understanding of Flavonoids as Anti-Tumor Agents, Anti-Cancer Agents in Medicinal Chemistry 2013; 13 (2) . https://dx.doi.org/10.2174/1871520611313020017
DOI https://dx.doi.org/10.2174/1871520611313020017 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy
Current Cancer Drug Targets Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives
Medicinal Chemistry Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Current Medicinal Chemistry Health Benefits of Manuka Honey as an Essential Constituent for Tissue Regeneration
Current Drug Metabolism Usefulness of Ancillary Methods for Diagnosis, Prognosis and Targeted Therapy in Thyroid Pathology
Current Medicinal Chemistry Bisphosphonate Therapy in the Treatment of Multiple Myeloma
Current Pharmaceutical Design Bioluminescence Imaging in Rodents: When Light Illuminates Cancer Research
Current Molecular Imaging (Discontinued) Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Graphical Abstracts
Letters in Drug Design & Discovery Clinical Trials in Children
Reviews on Recent Clinical Trials Circulating Exosomes as Potential Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design Selecting the Components for a Safe and Efficient Tuberculosis Subunit Vaccine - Recent Progress and Post-Genomic Insights
Current Pharmaceutical Biotechnology Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
Current Drug Safety Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition
Current Medicinal Chemistry Recent Technological Developments in Proteolytic 18O Labeling
Current Proteomics AP5346 (ProLindac™), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer
Current Bioactive Compounds Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase
Current Protein & Peptide Science Development of Small Molecular Probes for the Molecular Imaging of Apoptosis
Anti-Cancer Agents in Medicinal Chemistry